Business · 17/11/1995
FDA Announces Hearing on Proposal to Revoke Plascon, Inc.'s Licenses for Manufacturing Source Plasma
The FDA is seeking public input on a proposal to revoke Plascon, Inc.'s licenses due to repeated noncompliance with biologics regulations and license standards, affecting their Anderson Plasma Center manufacturing operations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →